Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
UCLA Medical Center, Los Angeles, California University of California, Irvine, Orange, California Stanford Hospital, Palo Alto, California University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa, Florida Karmanos Cancer Institute, Detroit, Michigan